Young Joseph R 4
4 · Vera Therapeutics, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR
Transactions
- Sale
Class A Common Stock
2025-11-11$29.06/sh−15,000$435,875→ 47,839 total - Exercise/Conversion
Class A Common Stock
2025-11-13$3.94/sh+10,000$39,396→ 57,839 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-13−10,000→ 48,589 totalExercise: $3.94Exp: 2031-04-13→ Class A Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $29.03 to $29.17, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Includes 893 ordinary shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan.
- [F3]1/4 of the shares subject to the option vest on March 9, 2022, and 1/48 of the shares vest monthly thereafter.